These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung. O'Brien S; Fothergill JL FEMS Microbiol Lett; 2017 Aug; 364(15):. PubMed ID: 28859314 [TBL] [Abstract][Full Text] [Related]
6. The Lung Microbiome of Three Young Brazilian Patients With Cystic Fibrosis Colonized by Fungi. de Almeida OGG; Capizzani CPDC; Tonani L; Grizante Barião PH; da Cunha AF; De Martinis ECP; Torres LAGMM; von Zeska Kress MR Front Cell Infect Microbiol; 2020; 10():598938. PubMed ID: 33262957 [TBL] [Abstract][Full Text] [Related]
7. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System. Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523 [TBL] [Abstract][Full Text] [Related]
8. Decreased susceptibility of Streptococcus anginosus to vancomycin in a multispecies biofilm is due to increased thickness of the cell wall. Tavernier S; Sass A; De Bruyne M; Baeke F; De Rycke R; Crabbé A; Vandecandelaere I; Van Nieuwerburgh F; Coenye T J Antimicrob Chemother; 2018 Sep; 73(9):2323-2330. PubMed ID: 29901811 [TBL] [Abstract][Full Text] [Related]
9. Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model. Rodríguez-Sevilla G; García-Coca M; Romera-García D; Aguilera-Correa JJ; Mahíllo-Fernández I; Esteban J; Pérez-Jorge C Int J Med Microbiol; 2018 Apr; 308(3):413-423. PubMed ID: 29555180 [TBL] [Abstract][Full Text] [Related]
10. In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members. Vandeplassche E; Sass A; Lemarcq A; Dandekar AA; Coenye T; Crabbé A Sci Rep; 2019 Sep; 9(1):12859. PubMed ID: 31492943 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967 [TBL] [Abstract][Full Text] [Related]
12. Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system. Jean-Pierre F; Hampton TH; Schultz D; Hogan DA; Groleau MC; Déziel E; O'Toole GA Elife; 2023 Jan; 12():. PubMed ID: 36661299 [TBL] [Abstract][Full Text] [Related]
13. Activity of Antibiotics against Pseudomonas aeruginosa in an Diaz Iglesias Y; Van Bambeke F Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015047 [No Abstract] [Full Text] [Related]
14. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics. Orazi G; Ruoff KL; O'Toole GA mBio; 2019 Jul; 10(4):. PubMed ID: 31363032 [No Abstract] [Full Text] [Related]
16. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients. Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530 [TBL] [Abstract][Full Text] [Related]
17. Impact of N-Acetylcysteine and Antibiotics Against Single and Dual Species Biofilms of Pseudomonas aeruginosa and Achromobacter xylosoxidans. Yilmaz FN; Hacioglu M; Aldogan EH Curr Microbiol; 2022 Nov; 80(1):5. PubMed ID: 36434296 [TBL] [Abstract][Full Text] [Related]
18. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972 [TBL] [Abstract][Full Text] [Related]
19. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986 [TBL] [Abstract][Full Text] [Related]
20. Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress. Lopes SP; Azevedo NF; Pereira MO Int J Med Microbiol; 2017 Dec; 307(8):460-470. PubMed ID: 29033313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]